Display Settings:

Format

Send to:

Choose Destination

    Am J Hum Genet. 1998 Nov;63(5):1307-15.

    A range of clinical phenotypes associated with mutations in CRX, a photoreceptor transcription-factor gene.

    Sohocki MM, Sullivan LS, Mintz-Hittner HA, Birch D, Heckenlively JR, Freund CL, McInnes RR, Daiger SP.

    Human Genetics Center, School of Public Health, The University of Texas Health Science Center, Houston, TX 77225-0334, USA.

    Mutations in the retinal-expressed gene CRX (cone-rod homeobox gene) have been associated with dominant cone-rod dystrophy and with de novo Leber congenital amaurosis. However, CRX is a transcription factor for several retinal genes, including the opsins and the gene for interphotoreceptor retinoid binding protein. Because loss of CRX function could alter the expression of a number of other retinal proteins, we screened for mutations in the CRX gene in probands with a range of degenerative retinal diseases. Of the 294 unrelated individuals screened, we identified four CRX mutations in families with clinical diagnoses of autosomal dominant cone-rod dystrophy, late-onset dominant retinitis pigmentosa, or dominant congenital Leber amaurosis (early-onset retinitis pigmentosa), and we identified four additional benign sequence variants. These findings imply that CRX mutations may be associated with a wide range of clinical phenotypes, including congenital retinal dystrophy (Leber) and progressive diseases such as cone-rod dystrophy or retinitis pigmentosa, with a wide range of onset.

    PMID: 9792858 [PubMed - indexed for MEDLINE]

    PMCID: 1377541

    Supplemental Content

    Click here to read Click here to read